Back Home

Webinar Information and Registration

Multiple Myeloma: Current Approaches to Managing Relapse and Refractory Disease

Tuesday, August 20, 2013, 1-2 pm EDT

Register Now (Webinar Already Occurred)

Wednesday, September 18, 2013, 2-3 pm EDT

Register Now

After registration, you will receive an e-mail confirmation with instructions for joining the webinar.

Download Handout

Accreditation for Pharmacists

ACPEThe American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity provides 1 hour (0.1 CEU) of continuing pharmacy education credit (activity # 0204-0000-13-460-L01-P). 

Methods and Format

This is a live web-based activity consisting of audio, presentation slides, and an activity evaluation tool.  Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit. Participants may print their official statements of continuing pharmacy education credit immediately following the activity.  This activity is provided free of charge. View full CE processing instructions.

Target Audience

This continuing pharmacy education activity was planned to meet the needs of health system pharmacists, especially those interested in hematology, oncology, new drug therapies, preventing resistance, and quality improvement.

Webinar Overview

Among the many challenges of managing patients with multiple myeloma is the fact that most patients eventually develop resistance to therapy. Several new treatment options have emerged over the past few years for managing relapse and refractory disease. This educational activity will review current options to address this challenge.

Time for questions and answers from the webinar audience will be provided at the end of the presentation.

Learning Objectives

At the conclusion of this application-based continuing education activity, participants should be able to

  • Review current and emerging treatment strategies for the management of patients with relapsed and refractory multiple myeloma.
  • Apply evidence-based approaches to managing the challenges in treating relapsed and refractory multiple myeloma.
  • Describe appropriate supportive care measures for patients receiving active treatment for multiple myeloma.

Faculty

Christopher A. FauselChristopher A. Fausel, Pharm.D., M.H.A., BCOP
Clinical Manager, Oncology Pharmacy
Indiana University Simon Cancer Center
Indiana University Health
Indianapolis, Indiana

Christopher A. Fausel, Pharm.D., M.H.A, BCOP, is Clinical Manager of Oncology Pharmacy at Indiana University Simon Cancer Center (IUSCC) in Indianapolis, Indiana. He oversees the clinical and dispensing pharmacy services at the IUSCC ambulatory infusion center and six satellite infusion clinics. Dr. Fausel holds academic appointments at the Department of Medicine at Indiana University School of Medicine, Purdue University School of Pharmacy and Pharmaceutical Sciences, and Butler University College of Pharmacy. He is the founding Residency Program Director for the postgraduate year two (PGY-2) oncology pharmacy residency at Indiana University Health. He serves on the Indiana University Purdue University at Indianapolis Institutional Review Board and Indiana University Simon Cancer Center Scientific Review Committee. 

Dr. Fausel received his Bachelor of Science degree in pharmacy and Doctor of Pharmacy degree from Albany College of Pharmacy in Albany, New York. He completed a pharmacy practice residency accredited by the American Society of Health-System Pharmacists (ASHP) at the Samuel S. Stratton VA Medical Center in Albany, New York. More recently, he earned a Master of Health Administration degree from Simmons College in Boston, Massachusetts.

Dr. Fausel is a board-certified oncology pharmacist (BCOP), and he is certified in basic life support by the American Red Cross. He is a member of the Hoosier Oncology Group Board of Directors and a long-standing member of ASHP, American Society of Clinical Oncology, and Hematology/Oncology Pharmacy Association.

Frequently Asked Questions for Webinars

What is a live webinar?
A live webinar brings the presentation to you – at your work place, in your home, through a staff in-service program.  You listen to the speaker presentation in “real time” as you watch the slides on the screen.  You will have the opportunity to ask the speaker questions at the end of the program.  Please join the conference at least 5 minutes before the scheduled start time for important announcements.

How do I process my Continuing Pharmacy Education (CPE) credit?
Continuing pharmacy education for this activity will be processed on ASHP’s new eLearning system and reported directly to CPE Monitor.  After completion of the live webinar, you will process your CPE and print your statement of credit online at http://elearning.ashp.org/my-activities. To process your CPE, you will need the enrollment code that will be announced at the end of the webinar. 

View full CE processing instructions (PDF).

What if I would like to arrange for my colleagues to participate in this webinar as a group?
One person serving as the group coordinator should register for the webinar.  That group coordinator will receive an e-mail confirmation with instructions for joining the webinar.  A few minutes before the webinar begins, the group coordinator should launch the webinar link. Once the webinar has been activated, the coordinator will have the option to open the audio via VoIP (Voice Over IP) on the webinar toolbar or use a touch tone phone with the provided dial-in information.  At the conclusion of the activity, the group coordinator will complete a brief online evaluation and report the number of participants at that site.  Each participant will process his or her individual continuing education statement online.

What do I need in order to participate in the webinar?
Computer with internet access and basic system requirements.  When you register, the webinar system will assess your system to ensure compatibility.

Telephone to dial the toll-free number and listen to the presentation (if you choose not to use Voice Over IP [VoIP] via your computer).

Webinar System Requirements
Be sure to view the webinar system requirements for Windows, Mac, iOS, and Android prior to the activity.

Sponsors Planned and conducted by ASHP Advantage and supported by educational grants from Millennium: The Takeda Oncology Company and Onyx Pharmaceuticals, Inc.